Immunovant, Inc. (IMVT)
24.76
+0.92
(+3.86%)
USD |
NASDAQ |
Mar 25, 16:00
24.70
-0.06
(-0.24%)
After-Hours: 07:45
Immunovant Shareholders Equity (Quarterly) : 986.14M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Boston Scientific Corp. | 24.23B |
| Plus Therapeutics, Inc. | 3.996M |
| Viridian Therapeutics, Inc. | 722.17M |
| Nutriband, Inc. | 7.549M |
| Definium Therapeutics, Inc. | 332.33M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.052B |
| Total Liabilities (Quarterly) | 66.26M |
| Current Ratio | 15.74 |
| Net Debt Paydown Yield | 0.00% |